Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Feb 1;51(2):e68-e69.
doi: 10.1097/CCM.0000000000005725. Epub 2023 Jan 20.

After the Rebranding and Cost Increase, the Use of Vasopressin Continues to Increase Yearly Especially in Case of Acute Kidney Injury With Septic Shock: Is There Recent Data Justifying It?

Patrick M Honore  1 , Sebastien Redant  2 , Pharan Djimafo  2 , Sydney Blackman  3 , Ibrahim Bousbiat  3 , Emily Perriens  3 , Thierry Preseau  4 , Bogdan Vasile Cismas  4 , Keitiane Kaefer  2 , Leonel Barreto Gutierrez  2 , Sami Anane  2 , Andrea Gallerani  2 , Rachid Attou  2
Affiliations
Comment

After the Rebranding and Cost Increase, the Use of Vasopressin Continues to Increase Yearly Especially in Case of Acute Kidney Injury With Septic Shock: Is There Recent Data Justifying It?

Patrick M Honore et al. Crit Care Med. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have disclosed that they do not have any potential conflicts of interest.

Comment in

  • The authors reply.
    Sacha GL, Kiser TH, Wright GC, Bauer SR. Sacha GL, et al. Crit Care Med. 2023 Feb 1;51(2):e69-e70. doi: 10.1097/CCM.0000000000005763. Epub 2023 Jan 20. Crit Care Med. 2023. PMID: 36661472 No abstract available.

Comment on

References

    1. Sacha GL, Kiser TH, Wright GC, et al.: Association between vasopressin rebranding and utilization in patients with septic shock. Crit Care Med. 2022; 50:644–654
    1. Gordon AC, Mason AJ, Thirunavukkarasu N, et al.: Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: The VANISH randomized clinical trial. JAMA. 2016; 316:509–518
    1. Russell JA, Walley KR, Singer J, et al.: Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008; 358:877–887
    1. Honore PM, Jacobs R, De Waele E, et al.: Vasopressin versus noradrenaline as initial therapy in septic shock. Is vasopressin-related renal protection doomed to “vanish” in the haze? Ann Transl Med. 2016; 4(Suppl 1):S47
    1. Okazaki N, Iguchi N, Evans RG, et al.: Beneficial effects of vasopressin compared with norepinephrine on renal perfusion, oxygenation, and function in experimental septic acute kidney injury. Crit Care Med. 2020; 48:e951–e958

MeSH terms

LinkOut - more resources